• Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K (1986) Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder. Psychopharmacol 88:484–488

  Google Scholar 

• Barth N, Manus M, E (1975) Arrhythmias and inhibition of noradrenaline uptake caused by tricyclic antidepressants and chlorpromazine on the isolated perfused rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 288:215–231

  Google Scholar 

• Barth N, Muscholl E (1974) The effects of the tricyclic antidepressants desipramine, doxepine and iprindole on the isolated perfused rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 284:215–232

  Google Scholar 

• Baum T, Shropshire AT, Rowles G, Gluckman MI (1971) Antidepressants and cardiac conduction: iprindole and imipramine. Eur J Pharmacol 13:287–291

  Google Scholar 

• Baumann PA, Maitre L (1977) Blockade of presynaptic α-receptors and of amine uptake in the rat brain by the antidepressant mianserine. Naunyn-Schmiedeberg's Arch Pharmacol 300:31–37

  Google Scholar 

• Burgess CD, Turner P (1978) Cardiovascular responses to mianserin hydrochloride: A comparison with tricyclic antidepressant drugs. Br J Clin Pharmacol 5 (Suppl 1):21S–28S

  Google Scholar 

• Coppen A, Gupta R, Montgomery S, Ghose K, Bailey J, Burns B, De Ridder JJ (1976) Mianserin hydrochloride: A novel antidepressant. Br J Psychiat 129:342–345

  Google Scholar 

• Coppen A, Kopera H (1978) Workshop on the clinical pharmacology and efficacy of mianserin. Br J Clin Pharmacol 5 (Suppl 1):91S–99S

  Google Scholar 

• Coull DC, Crooks J, Dingwall-Fordyce I, Scott AM, Weir RD (1970) A method of comonitoring drugs for adverse reaction. II. Amitriptyline and cardiac disease. Eur J Clin Pharmacol 3:51–55

  Google Scholar 

• Edwards JG, Goldie A (1983) Mianserin, maprotiline and intracardiac conduction. Br J Clin Pharmacol 15 (Suppl 2):249S–254S

  Google Scholar 

• El-Sherif N, Scherlag BJ, Lazzara R, Hope RR (1977a) Re-entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone. Circulation 55:686–702

  Google Scholar 

• El-Sherif N, Hope RR, Scherlag BJ, Lazzara R (1977b) Re-entrant ventricular arrhythmias in the late myocardial infarction periods. 2. Patterns of initiation and termination of re-entry. Circulation 55:702–719

  Google Scholar 

• Feighner JP (1986) A review of controlled studies of adinazolam mesylate in patients with major depressive disorder. Psychopharmacol Bull 22:186–191

  Google Scholar 

• Ghose K, Coppen A, Turner P (1976) Autonomic actions and interactions of mianserin hydrochloride and amitriptyline in patients with depressive illness. Psychopharmacol 49:201–204

  Google Scholar 

• Harper B, Hughes IE (1977) A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake. Br J Pharmacol 59:651–660

  Google Scholar 

• Harris AS (1950) Delayed development of ventricular ectopic rhythm following experimental coronary occlusion. Circulation 1:1318–1329

  Google Scholar 

• Hopman H (1980) Mianserin, out-patients with depressive illness, in dosage up to 130 mg daily. Curr Med Res Opin 6 (Suppl 7) 107–114

  Google Scholar 

• Junien JL, Lakatos C, Padioleau F (1976) Studies of the effects of imipramine on cardiac conduction in anesthetized dogs by His bundle electrogram recording. J Cardiovasc Pharmacol 7:133–138

  Google Scholar 

• Kopera RA (1980) Cardiac effects of mianserin: results of clinical pharmacological investigation. Curr Med Res Opin 6:36–42

  Google Scholar 

• Lahti RA, Pyke RE, Sethy VH (1984) Adinazolam, a triazolobenzodiazepine antidepressant. Preclinical and clinical data. In: IUPHAR 9th International Congress of Pharmacology. The Macmillan Press, London, abstract 1983P

  Google Scholar 

• Marshall JB, Forker AD (1982) Cardiovascular effects of tricyclic antidepressant drugs: Therapeutic usage, overdose, and management of complications. AM Heart J 103:401–414

  Google Scholar 

• Matsuo S (1967) Comparative effects of imipramine and propranolol on the transmembrane potentials of the isolated rabbit's atria. Jap J Pharmacol 17:279–286

  Google Scholar 

• Moir OC, Cornwell WB, Dingwall-Fordyce I, Crooks J, O'Malley K, Turnbull MJ (1972) Cardiotoxicity of amitriptyline. The Lancet 2:561–564

  Google Scholar 

• Montgomery S (1983) Advances with antidepressants: clinical experiences with mianserin. Act Psychiat Scand 67 (Suppl. 305):90–94

  Google Scholar 

• Nattel S (1985) Frequency-dependent effects of amitriptyline on ventricular conduction and cardiac rhythm in dogs. Circulation 72:1423–1428

  Google Scholar 

• Nishimoto M, Hashimoto H, Ozaki T, Nagashima S, Nakashima M (1989) Comparative effects of antidepressants, amitriptyline, mianserin and adinazolam, on hemodynamics and ECG in myocardial infarcted dogs. Arch Int Pharmacodyn Ther 299:98–109

  Google Scholar 

• Pyke RE, Cohn JB, Feighner JP, Smith WT (1983) Open-label studies of adinazolam in severe depression. Psychopharmacol Bull 19:96–98

  Google Scholar 

• Turmel A, De Montigny C (1984) Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine. Eur J Pharmacol 99:241–244

  Google Scholar 

• Vohra J, Burrows G, Hunt D, Sloman G (1975) The effects of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol 3:219–227

  Google Scholar 

• Wester HA, Siegers CP (1980) Cardiovascular effects of mianserin and amitriptyline in healthy volunteers. Int J Clin Pharmac Biopharmacy 18:513–517

  Google Scholar 

• Wishnie HA, Hackett TP, Cassem NH (1970) Psychological hazards of convalescence following myocardial infarction. JAMA 215:1292–1298

  Google Scholar 

Download references